Citi downgrades Merck to neutral, says drug pipeline struggles will hold stock back

Published Mon, Nov 29 20215:56 AM EST

Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021.

NurPhoto | NurPhoto | Getty Images

Disappointing results for some major drugs has limited the upside for Merck's stock, according to Citi.

More In Analyst Calls